QUESTIONSPharmacovigilance and Risk Management 2011
Venue: Renaissance Washington, DC Hotel
Location: Washington, Washington DC, United States
| Event Date/Time: Jan 09, 2011 | End Date/Time: Jan 12, 2011 |
Report as SpamDescription
Several preconference workshops are being developed and will be offered on January 9, 2011. Monitor www.diahome.org for information as it becomes available.
Conference Overview
Clinical trial safety and postmarketing pharmacovigilance is more critical than ever in the development and evaluation of the safe use of marketed medical products. This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.†This program will focus primarily on drug products and biologics, but medical devices will have a limited role in the discussions.
Event Code:
11002
Conference Overview
Clinical trial safety and postmarketing pharmacovigilance is more critical than ever in the development and evaluation of the safe use of marketed medical products. This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.†This program will focus primarily on drug products and biologics, but medical devices will have a limited role in the discussions.
Event Code:
11002
Venue
Additional Information
TABLETOP EXHIBIT INFORMATION
Attendees may visit the tabletop exhibits during the event and receptions.
For further information, contact Jeff Korn, Exhibits Associate,
Phone +1.215.442.6184 / Fax +1.215.442.6199, email Jeff.Korn@diahome.org
